|
|
|
Insider
Information: |
Hsiao Jane Ph D |
Relationship: |
|
City: |
|
State: |
|
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
7 |
|
Direct
Shares |
49,658,203 |
|
Indirect Shares
|
33,836,183 |
|
|
Direct
Value |
$46,236,525 |
|
|
Indirect Value
|
$19,384,145 |
|
|
Total
Shares |
83,494,386 |
|
|
Total
Value |
$65,620,669 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
4
|
0
|
Stock
price went up :
|
3
|
0
|
Stock
price went down : |
1
|
0
|
|
|
|
Gain/Loss Ratio : |
3.0
|
0.0
|
Percentage
Gain/Loss : |
12.7%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Asensus Surgical Inc |
ASXC |
Director |
2021-07-01 |
336,895 |
2021-07-01 |
96,746 |
Premium* |
|
Protalix Biotherapeutics |
PLX |
Director |
2007-01-31 |
1,134,060 |
|
0 |
Premium* |
|
Opko Health Inc |
OPK |
|
2024-01-17 |
27,999,880 |
2024-01-17 |
5,127,404 |
Premium* |
|
Prolor Biotech Inc |
PBTH |
Director |
2013-08-29 |
0 |
2013-08-29 |
0 |
Premium* |
|
Non Invasive Monitoring Systems ... |
NIMU |
Interim CEO, Director,... |
2018-12-21 |
16,752,074 |
2018-12-21 |
20,883,660 |
Premium* |
|
Sorrento Therapeutics Inc |
SRNE |
Director |
|
0 |
2010-01-25 |
2,231,719 |
Premium* |
|
Cocrystal Pharma |
COCP |
|
2016-03-15 |
3,435,294 |
2016-03-15 |
5,496,654 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
NIMU |
Non Invasive Monitoring S... |
Interim CEO |
|
2018-12-21 |
4 |
B |
$0.07 |
$1,461,856 |
I/I |
20,883,660 |
20,883,660 |
2.64 |
- |
|
NIMU |
Non Invasive Monitoring S... |
Interim CEOChairman of the Boa |
|
2013-04-08 |
4 |
B |
$0.05 |
$1,000,000 |
D/D |
20,000,000 |
10,400,000 |
3.23 |
- |
|
OPK |
Opko Health Inc |
Director |
|
2007-03-27 |
4/A |
A |
$0.00 |
$0 |
D/D |
11,604,144 |
11,604,144 |
0 |
- |
|
OPK |
Opko Health Inc |
Director |
|
2007-03-27 |
4 |
A |
$0.00 |
$0 |
D/D |
11,604,144 |
4,095,581 |
0 |
- |
|
NIMU |
Non Invasive Monitoring S... |
Interim CEO |
|
2018-12-21 |
4 |
B |
$0.07 |
$444,645 |
D/D |
6,352,074 |
16,752,074 |
3.23 |
- |
|
COCP |
Cocrystal Pharma |
|
|
2015-03-03 |
4 |
OE |
$0.00 |
$0 |
I/I |
5,496,654 |
5,496,654 |
0 |
- |
|
OPK |
Opko Health Inc |
Vice Chairman & CTO |
|
2015-01-31 |
4 |
OE |
$0.00 |
$2,300,550 |
I/I |
4,796,158 |
20,286,704 |
0 |
- |
|
ASXC |
Asensus Surgical Inc |
Chairman of the Board |
|
2012-02-17 |
4 |
B |
$0.40 |
$1,800,000 |
D/D |
4,500,000 |
7,303,965 |
3.92 |
- |
|
ASXC |
Asensus Surgical Inc |
Director |
|
2013-12-06 |
4 |
OE |
$0.40 |
$1,750,000 |
I/I |
4,375,000 |
6,288,470 |
0 |
- |
|
ASXC |
Asensus Surgical Inc |
Director |
|
2013-12-06 |
4 |
OE |
$0.40 |
$1,750,000 |
D/D |
4,375,000 |
15,812,681 |
0 |
- |
|
OPK |
Opko Health Inc |
Chief Technology Officer |
|
2007-12-04 |
4 |
B |
$1.84 |
$7,500,000 |
D/D |
4,076,087 |
9,171,668 |
2.81 |
- |
|
ASXC |
Asensus Surgical Inc |
Chairman of the Board |
|
2013-03-22 |
4 |
B |
$0.25 |
$1,000,000 |
D/D |
4,000,000 |
11,437,681 |
3.92 |
- |
|
OPK |
Opko Health Inc |
Vice Chairman & CTO |
|
2015-01-31 |
4 |
OE |
$0.67 |
$2,512,440 |
D/D |
2,936,580 |
24,584,375 |
0 |
- |
|
ASXC |
Asensus Surgical Inc |
Director |
|
2007-09-04 |
4 |
A |
$0.00 |
$0 |
D/D |
2,588,965 |
2,803,965 |
0 |
- |
|
COCP |
Cocrystal Pharma |
|
|
2015-03-25 |
4 |
B |
$0.92 |
$2,024,000 |
D/D |
2,200,000 |
2,200,000 |
2.39 |
- |
|
OPK |
Opko Health Inc |
Chief Technology Officer |
|
2008-02-11 |
4 |
B |
$1.80 |
$3,600,000 |
I/I |
2,000,000 |
17,490,546 |
2.66 |
- |
|
NIMU |
Non Invasive Monitoring S... |
Interim CEOChairman of the Boa |
|
2013-04-08 |
4/A |
B |
$0.05 |
$100,000 |
D/D |
2,000,000 |
10,400,000 |
3.23 |
- |
|
OPK |
Opko Health Inc |
Vice Chairman & CTO |
|
2018-12-13 |
4 |
GD |
$0.00 |
$0 |
I/I |
2,000,000 |
0 |
0 |
- |
|
PBTH |
Prolor Biotech Inc |
Director |
|
2013-08-29 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,874,666) |
0 |
0 |
- |
|
OPK |
Opko Health Inc |
Vice Chairman & CTO |
|
2013-08-29 |
4 |
A |
$0.00 |
$0 |
D/D |
1,865,481 |
19,770,712 |
0 |
- |
|
OPK |
Opko Health Inc |
See Remarks |
|
2008-08-08 |
4 |
A |
$1.11 |
$1,999,998 |
I/I |
1,801,800 |
2,354,800 |
0 |
- |
|
OPK |
Opko Health Inc |
Vice Chairman & CTO |
|
2013-12-13 |
4 |
OE |
$1.16 |
$4,729,000 |
D/D |
1,537,500 |
21,308,212 |
0 |
- |
|
ASXC |
Asensus Surgical Inc |
Chairman of the Board |
|
2010-06-15 |
4 |
B |
$1.00 |
$1,300,000 |
I/I |
1,300,000 |
1,360,000 |
2.25 |
- |
|
COCP |
Cocrystal Pharma |
|
|
2016-03-15 |
4 |
B |
$0.51 |
$630,000 |
D/D |
1,235,294 |
3,435,294 |
2.39 |
- |
|
OPK |
Opko Health Inc |
Vice Chairman & CTO |
|
2011-10-05 |
4 |
B |
$3.60 |
$4,320,000 |
I/I |
1,200,000 |
4,297,800 |
2.64 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|